SERIAL #79457548
LIVE

Serial Number

79457548

Owner

Voronoi, Inc.

Filing Date

Jun 25, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79457548 Trademark

Serial Number: 79457548

Serial #79457548 is a trademark filed by Voronoi, Inc. on June 25, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Voronoi, Inc.

S-18th F, Bldg. 32 Songdogwahak-ro,

Entity Type: 03

Trademark Details

Filing Date

June 25, 2026

Registration Date

Not Registered

Goods & Services

Medical diagnostic assays for analyzing proteins; database design and development; scientific research conducted using databases; research relating to molecular sciences; research and development services of new pharmaceutical products using molecular modelling; research laboratory analysis services in the field of molecular biology; development of computer software for big data processing; technical data analysis services in the field of biotechnology; development of pharmaceuticals for cell therapies; development, updating and maintenance of software and database systems; drug discovery services; scientific research for medical purposes in the area of cancerous diseases; development of pharmaceutical preparations and medicines; consultancy relating to pharmaceutical research and development; technical consultancy in the field of development of computer software for analyzing medical and biotechnological data; providing personalized medical data interpretation services, namely, medical data analysis services; research services in the field of pharmaceutical preparations; consultancy in the field of testing, inspection, research of pharmaceutical products; providing information on the testing, inspection and research of pharmaceutical products; medical and pharmacological research services; development of computer hardware for artificial intelligence services; research and development of computer software platforms for artificial intelligence services; development of computer software for artificial intelligence services.

Pharmaceutical preparations for the treatment of osteoporosis; pharmaceutical preparations and compositions for the treatment and prevention of protein kinase-related diseases; pharmaceutical preparations for treating metabolic disorders; cardiovascular pharmaceutical preparations; cardiovascular treatment preparations; pharmaceutical preparations and compositions for the treatment and prevention of cancer; biopharmaceutical preparations for the treatment of cancer; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the prevention of inflammatory diseases; pharmaceutical preparations for the treatment of inflammatory diseases; chemical preparations for medical purposes, namely, for the treatment of cancer; enzymes for medical purposes; pharmaceutical compositions for use in treatment and prevention of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the prevention of autoimmune diseases; pharmaceutical preparations for the treatment of autoimmune diseases; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for treating tumors; pharmaceutical preparations for the diagnosis of cancer; pharmaceutical preparations for neurodegenerative diseases; pharmaceutical preparations for the treatment of Parkinson's disease; pharmaceutical preparations for the treatment of lung cancer; antidiabetic preparations.

Filing History

LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 21, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2026 REPR